Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway

[1]  G. Fuller,et al.  Inhibition of p-STAT3 Enhances IFN-α Efficacy against Metastatic Melanoma in a Murine Model , 2010, Clinical Cancer Research.

[2]  H. Colman,et al.  Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression , 2010, Clinical Cancer Research.

[3]  Howard Colman,et al.  Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cells. , 2010, Journal of proteome research.

[4]  J. Uhm,et al.  The transcriptional network for mesenchymal transformation of brain tumours , 2010 .

[5]  B. Cochran,et al.  STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells , 2009, Stem cells.

[6]  H. Colman,et al.  Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transporters , 2009, Oncogene.

[7]  Erwin G. Van Meir,et al.  Stat3 activation is required for the growth of U87 cell-derived tumours in mice. , 2009, European journal of cancer.

[8]  G. Rao,et al.  A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells , 2009, Cancer Immunology, Immunotherapy.

[9]  David S. Yang,et al.  The Incidence, Correlation with Tumor-Infiltrating Inflammation, and Prognosis of Phosphorylated STAT3 Expression in Human Gliomas , 2008, Clinical Cancer Research.

[10]  P. Steeg,et al.  Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis. , 2008, Cancer research.

[11]  B. Hoffman,et al.  Apoptotic signaling by c-MYC , 2008, Oncogene.

[12]  Gerald C. Chu,et al.  P53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation , 2008, Nature.

[13]  F. Ali-Osman,et al.  Constitutively Activated STAT3 Frequently Coexpresses with Epidermal Growth Factor Receptor in High-Grade Gliomas and Targeting STAT3 Sensitizes Them to Iressa and Alkylators , 2008, Clinical Cancer Research.

[14]  N. D. Clarke,et al.  Integration of External Signaling Pathways with the Core Transcriptional Network in Embryonic Stem Cells , 2008, Cell.

[15]  J. Rich,et al.  Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  B. Aggarwal,et al.  Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1. , 2008, Cancer research.

[17]  K. Aldape,et al.  Brain tumor stem cells. , 2008, Current problems in cancer.

[18]  Emily C. Brantley,et al.  Signal Transducer and Activator of Transcription-3: A Molecular Hub for Signaling Pathways in Gliomas , 2008, Molecular Cancer Research.

[19]  Ying-Xuan Chen,et al.  Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. , 2008, Neoplasia.

[20]  Olov Sterner,et al.  Galiellalactone is a novel therapeutic candidate against hormone‐refractory prostate cancer expressing activated Stat3 , 2008, The Prostate.

[21]  D. Germain,et al.  Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3. , 2008, Cancer research.

[22]  A. Kung,et al.  Anti-apoptosis mechanisms in malignant gliomas. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Yuri Kotliarov,et al.  Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. , 2008, Cancer cell.

[24]  A. Heimberger,et al.  Small molecular inhibitors of p-STAT3: novel agents for treatment of primary and metastatic CNS cancers. , 2008, Recent patents on CNS drug discovery.

[25]  Gerald C. Chu,et al.  Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma. , 2008, Cold Spring Harbor symposia on quantitative biology.

[26]  Z. Estrov,et al.  WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells. , 2007, Cancer research.

[27]  R. Kishore,et al.  STAT3-Dependent Mouse Embryonic Stem Cell Differentiation Into Cardiomyocytes: Analysis of Molecular Signaling and Therapeutic Efficacy of Cardiomyocyte Precommitted mES Transplantation in a Mouse Model of Myocardial Infarction , 2007, Circulation research.

[28]  J. Margolick,et al.  Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance , 2007, Proceedings of the National Academy of Sciences.

[29]  D. Germain,et al.  Targeting the Cytoplasmic and Nuclear Functions of Signal Transducers and Activators of Transcription 3 for Cancer Therapy , 2007, Clinical Cancer Research.

[30]  H. Colman,et al.  Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. , 2007, Journal of the National Cancer Institute.

[31]  H. Takada,et al.  Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome , 2007, Nature.

[32]  J. Pouysségur,et al.  The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition , 2007, Oncogene.

[33]  C. Der,et al.  Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer , 2007, Oncogene.

[34]  Alexander Brawanski,et al.  CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. , 2007, Cancer research.

[35]  Hiroyuki Mori,et al.  Potentiation of Astrogliogenesis by STAT3-Mediated Activation of Bone Morphogenetic Protein-Smad Signaling in Neural Stem Cells , 2007, Molecular and Cellular Biology.

[36]  K. Hess,et al.  A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo , 2007, Oncogene.

[37]  R. Eisenberg,et al.  Activation state EGFR and STAT-3 as prognostic markers in resected non-small cell lung cancer. , 2007, Lung cancer.

[38]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[39]  K. Black,et al.  Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma , 2006, Molecular Cancer.

[40]  B. Aggarwal,et al.  Targeting Signal‐Transducer‐and‐Activator‐of‐Transcription‐3 for Prevention and Therapy of Cancer , 2006, Annals of the New York Academy of Sciences.

[41]  D. Louis,et al.  Activation of STAT3, MAPK, and AKT in Malignant Astrocytic Gliomas: Correlation With EGFR Status, Tumor Grade, and Survival , 2006, Journal of neuropathology and experimental neurology.

[42]  Irving L Weissman,et al.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.

[43]  Daniel J. Hoeppner,et al.  Notch signalling regulates stem cell numbers in vitro and in vivo , 2006, Nature.

[44]  Y. Hanakawa,et al.  Overexpression of SOCS3 inhibits astrogliogenesis and promotes maintenance of neural stem cells , 2006, Journal of neurochemistry.

[45]  S. Akira,et al.  Non-cell-autonomous action of STAT3 in maintenance of neural precursor cells in the mouse neocortex , 2006, Development.

[46]  Yuri Kotliarov,et al.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.

[47]  J. Dick,et al.  Cancer stem cells: lessons from leukemia. , 2005, Trends in cell biology.

[48]  K. Sugasawa,et al.  Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation. , 2005, Cancer research.

[49]  Jing-Yuan Fang,et al.  The MAPK signalling pathways and colorectal cancer. , 2005, The Lancet. Oncology.

[50]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[51]  D. Farkas,et al.  Isolation of cancer stem cells from adult glioblastoma multiforme , 2004, Oncogene.

[52]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[53]  M. Weller,et al.  Apoptosis in Gliomas: Molecular Mechanisms and Therapeutic Implications , 2004, Journal of Neuro-Oncology.

[54]  Ugo Orfanelli,et al.  Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma , 2004, Cancer Research.

[55]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[56]  Huang Shao,et al.  Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor. , 2003, Cancer research.

[57]  G. Barnett,et al.  Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells , 2002, Oncogene.

[58]  J. Pow-Sang,et al.  Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. , 2002, Cancer research.

[59]  Hua Yu,et al.  Roles of activated Src and Stat3 signaling in melanoma tumor cell growth , 2002, Oncogene.

[60]  J. Darnell,et al.  Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.

[61]  J. Bromberg.  Stat proteins and oncogenesis. , 2002, The Journal of clinical investigation.

[62]  R. Gottlieb,et al.  Analyzing mitochondrial changes during apoptosis. , 2002, Methods.

[63]  G. Fuller,et al.  Constitutive activation of Stat3α in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2) , 2002, Oncogene.

[64]  A. Sadikot,et al.  Isolation of multipotent adult stem cells from the dermis of mammalian skin , 2001, Nature Cell Biology.

[65]  T. Yeatman,et al.  Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Hua Yu,et al.  Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells , 2001, Oncogene.

[67]  J. Darnell,et al.  The role of STATs in transcriptional control and their impact on cellular function , 2000, Oncogene.

[68]  D. van der Kooy,et al.  Retinal stem cells in the adult mammalian eye. , 2000, Science.

[69]  G. Fuller,et al.  An implantable guide-screw system for brain tumor studies in small animals. , 2000, Journal of neurosurgery.

[70]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[71]  C. Geisler,et al.  Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells , 1999, Leukemia.

[72]  T. Hirano,et al.  STAT3 orchestrates contradictory signals in cytokine‐induced G1 to S cell‐cycle transition , 1998, The EMBO journal.

[73]  P. Roberson,et al.  Transcriptional Activation of the p21 WAF1,CIP1,SDI1 Gene by Interleukin-6 Type Cytokines , 1998, The Journal of Biological Chemistry.

[74]  Z. Xia,et al.  Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts. , 1998, Cancer research.

[75]  J. Darnell.  STATs and gene regulation. , 1997, Science.

[76]  S. Akira,et al.  Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[77]  Xiaodong Wang,et al.  Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.

[78]  S. Weiss,et al.  Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. , 1996, Developmental biology.

[79]  A. Levitzki,et al.  Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor , 1996, Nature.

[80]  T. Hunter,et al.  Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.

[81]  M. Caligiuri,et al.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.

[82]  T. Hunter,et al.  Cyclins and cancer , 1991, Cell.

[83]  D. W. Weiss,et al.  Immunology of spontaneous mammary carcinomas in mice. V. Acquired tumor resistance and enhancement in strain A mice infected with mammary tumor virus. , 1966, Cancer research.

[84]  D. W. Weiss,et al.  Immunology of Spontaneous Mammary Carcinomas in Mice , 1966 .